DAFNA Capital Management as of March 31, 2014
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 46 positions in its portfolio as reported in the March 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Discovery Laboratories | 10.5 | $12M | 5.7M | 2.15 | |
| Pharmacyclics | 9.5 | $11M | 111k | 100.22 | |
| AtriCure (ATRC) | 9.2 | $11M | 571k | 18.81 | |
| Ampio Pharmaceuticals | 8.9 | $10M | 1.6M | 6.35 | |
| Novadaq Technologies | 5.0 | $5.9M | 264k | 22.28 | |
| Stereotaxis (STXS) | 5.0 | $5.9M | 1.4M | 4.25 | |
| Protalix BioTherapeutics | 4.6 | $5.4M | 1.2M | 4.58 | |
| Insulet Corporation (PODD) | 4.5 | $5.2M | 109k | 47.42 | |
| NxStage Medical | 4.2 | $4.9M | 384k | 12.74 | |
| Derma Sciences | 4.2 | $4.9M | 385k | 12.68 | |
| Insulet Corporation Cvt 3.75 0 convert | 4.1 | $4.8M | 2.6M | 1.81 | |
| Biota Pharmaceuticals | 3.8 | $4.5M | 730k | 6.11 | |
| Merrimack Pharmaceuticals In | 2.2 | $2.6M | 515k | 5.04 | |
| Galmed Pharmaceuticals | 2.0 | $2.3M | 202k | 11.47 | |
| Biotelemetry | 1.9 | $2.2M | 216k | 10.09 | |
| BioSpecifics Technologies | 1.6 | $1.8M | 70k | 25.92 | |
| Keryx Biopharmaceuticals | 1.5 | $1.7M | 100k | 17.04 | |
| Threshold Pharmaceuticals | 1.1 | $1.3M | 271k | 4.76 | |
| Spectranetics Corporation | 1.1 | $1.3M | 42k | 30.31 | |
| Nuvasive Inc. conv | 1.0 | $1.2M | 1.0M | 1.19 | |
| XenoPort | 1.0 | $1.1M | 220k | 5.17 | |
| Syneron Medical Ltd ord | 1.0 | $1.1M | 91k | 12.45 | |
| Cardica | 0.9 | $1.1M | 1.1M | 1.00 | |
| Uroplasty | 0.9 | $1.1M | 289k | 3.63 | |
| Cutera (CUTR) | 0.8 | $992k | 89k | 11.18 | |
| Johnson & Johnson (JNJ) | 0.8 | $923k | 9.4k | 98.19 | |
| Clovis Oncology | 0.8 | $873k | 13k | 69.29 | |
| Inspiremd | 0.8 | $875k | 287k | 3.05 | |
| Adamis Pharmaceuticals Corp Com Stk | 0.7 | $795k | 125k | 6.36 | |
| Cytrx | 0.7 | $785k | 225k | 3.49 | |
| Exactech | 0.6 | $713k | 32k | 22.54 | |
| RTI Biologics | 0.6 | $682k | 167k | 4.08 | |
| Immunocellular Thera | 0.6 | $691k | 567k | 1.22 | |
| Intercept Pharmaceuticals In | 0.6 | $660k | 2.0k | 330.00 | |
| Ocera Therapeutics | 0.6 | $667k | 63k | 10.55 | |
| Lpath | 0.4 | $499k | 105k | 4.75 | |
| Masimo Corporation (MASI) | 0.4 | $478k | 18k | 27.31 | |
| Curis | 0.4 | $423k | 150k | 2.82 | |
| AVEO Pharmaceuticals | 0.3 | $392k | 262k | 1.50 | |
| Celsus Therapeutics Plc sponsored adr ne | 0.2 | $285k | 44k | 6.49 | |
| Genvec | 0.2 | $265k | 100k | 2.65 | |
| Tonix Pharmaceuticls | 0.2 | $260k | 25k | 10.40 | |
| Venaxis | 0.2 | $192k | 73k | 2.63 | |
| Chembio Diagnostics | 0.2 | $190k | 55k | 3.44 | |
| Alcobra | 0.1 | $175k | 9.6k | 18.19 | |
| Retractable Technologies (RVP) | 0.1 | $76k | 20k | 3.80 |
